Myriad Genetics Inc. is a molecular diagnostic company that focuses on developing and marketing genetic tests to assess predisposition to certain diseases, especially in oncology, urology, and other health areas.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!